Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2093505 | 0.78 | RAPGEF4 (0.50) | NPC1MEN1MAPTKMT2ARAB9A | |
| SCHEMBL10895040 | 0.78 | TSHR (0.50) | EPHX1EPHX2CA2MAPTLMNA | |
| SCHEMBL12614443 | 0.78 | RAPGEF4 (0.59) | EPHX1EPHX2CA2CA4CA5A | |
| SCHEMBL11611979 | 0.76 | EPHX1 (0.54) | EPHX1EPHX2CA2CA4CA5A | |
| SCHEMBL19828138 | 0.74 | EPHX1 (0.52) | EPHX1EPHX2CA2CA4CA5A | |
| SCHEMBL11052606 | 0.74 | EPHX1 (0.58) | EPHX1EPHX2CA2CA4CA5A | |
| SCHEMBL29502263 | 0.74 | MAPT (0.55) | EPHX1EPHX2CA2CA4CA5A | |
| SCHEMBL856883 | 0.74 | EPHX1 (0.52) | EPHX1EPHX2CA2CA4CA5A | |
| SCHEMBL28391249 | 0.74 | EPHX1 (0.52) | EPHX1EPHX2CA2CA4CA5A | |
| SCHEMBL30667273 | 0.74 | EPHX1 (0.52) | EPHX1EPHX2CA2CA4CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115322163-B | Dicarboxamido tetrazine compound as VEGFR-2 inhibitor and preparation and application thereof | 浙江工业大学 | 2024-04-09 | — | — | CN | claimed |
| CN-115322163-A | Di-methylamino-s-tetrazine compound as VEGFR-2 inhibitor and preparation and application thereof | 浙江工业大学 | 2022-11-11 | — | — | CN | claimed |
| CN-115322163-B | Dicarboxamido tetrazine compound as VEGFR-2 inhibitor and preparation and application thereof | 浙江工业大学 | 2024-04-09 | — | — | CN | disclosed |
| CN-115322163-B | Dicarboxamido tetrazine compound as VEGFR-2 inhibitor and preparation and application thereof | 浙江工业大学 | 2024-04-09 | — | — | CN | disclosed |
| CN-115322163-A | Di-methylamino-s-tetrazine compound as VEGFR-2 inhibitor and preparation and application thereof | 浙江工业大学 | 2022-11-11 | — | — | CN | disclosed |
| CN-115322163-A | Di-methylamino-s-tetrazine compound as VEGFR-2 inhibitor and preparation and application thereof | 浙江工业大学 | 2022-11-11 | — | — | CN | disclosed |
| CN-114174281-A | Degradation agent for cyclin dependent kinase 7(CDK7) and use thereof | 达纳-法伯癌症研究公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-113993519-A | Degradation agent for cyclin dependent kinase 12(CDK12) and use thereof | 达纳-法伯癌症研究公司 | 2022-01-28 | — | — | CN | disclosed |